ESC-HF Renal Dysfunction Algorithm Calculator
Patient assessment
Enter the patient's clinical characteristics to calculate the original file's point total.
Not validated
Clinical context
Kidney dysfunction commonly coexists with heart failure and is associated with adverse outcomes. Interpretation requires more than a single eGFR value: consider baseline kidney function, changes in creatinine/eGFR over time, volume status, perfusion, medications, electrolytes, and albuminuria where appropriate.
How the supplied point system works
| Variable | Rule in original code | Points |
|---|---|---|
| eGFR | <30 / 30–<60 / 60–<90 / ≥90 | 3 / 2 / 1 / 0 |
| NYHA class | III or IV | 2 |
| Age | ≥75 years | 1 |
| Diabetes | Present | 1 |
| Hypertension | Present | 1 |
The original code classified totals ≤2, 3–5, and ≥6 as low, intermediate, and high risk. The redesign preserves its arithmetic but relabels the bands to avoid implying validated clinical risk.
Evidence and limitations
The 2021 ESC heart failure guideline discusses the relationship between heart failure and kidney dysfunction, including prognostic significance and the need to interpret renal changes in clinical context. It does not substantiate the specific point weights and risk bands implemented in the supplied PHP file.
Reference
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42:3599–3726.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.